- Home
- FRSX vs NRXS Comparison
FRSX vs NRXS Comparison
Compare FRSX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- NRXS
- Stock Information
- Founded
- FRSX N/A
- NRXS 2011
- Country
- FRSX Israel
- NRXS United States
- Employees
- FRSX N/A
- NRXS N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- NRXS
- Sector
- FRSX Technology
- NRXS
- Exchange
- FRSX Nasdaq
- NRXS Nasdaq
- Market Cap
- FRSX 11.4M
- NRXS 13.0M
- IPO Year
- FRSX 2017
- NRXS 2023
- Fundamental
- Price
- FRSX $0.55
- NRXS $2.61
- Analyst Decision
- FRSX
- NRXS
- Analyst Count
- FRSX 0
- NRXS 0
- Target Price
- FRSX N/A
- NRXS N/A
- AVG Volume (30 Days)
- FRSX 209.3K
- NRXS 4.9M
- Earning Date
- FRSX 06-17-2025
- NRXS 05-12-2025
- Dividend Yield
- FRSX N/A
- NRXS N/A
- EPS Growth
- FRSX N/A
- NRXS N/A
- EPS
- FRSX N/A
- NRXS N/A
- Revenue
- FRSX $436,000.00
- NRXS $2,934,945.00
- Revenue This Year
- FRSX N/A
- NRXS $138,883.78
- Revenue Next Year
- FRSX N/A
- NRXS $118.59
- P/E Ratio
- FRSX N/A
- NRXS N/A
- Revenue Growth
- FRSX N/A
- NRXS 27.52
- 52 Week Low
- FRSX $0.51
- NRXS $1.33
- 52 Week High
- FRSX $2.63
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- FRSX 39.88
- NRXS 50.48
- Support Level
- FRSX $0.53
- NRXS $2.57
- Resistance Level
- FRSX $0.66
- NRXS $2.82
- Average True Range (ATR)
- FRSX 0.03
- NRXS 0.44
- MACD
- FRSX -0.00
- NRXS -0.05
- Stochastic Oscillator
- FRSX 30.92
- NRXS 10.25
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).